6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline

C174H96N30 — CID 161318448

IUPAC6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline
SMILESc1ccc2cc(-c3nc(-c4ccc5ncccc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9ncccc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1ccc2cc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1cnc2ccc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ncccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)cc2c1
InChIInChI=1S/C60H34N8.C58H32N10.C56H30N12/c1-3-9-39-31-43(15-13-35(39)7-1)55-63-57(45-21-27-51-41(33-45)11-5-29-61-51)67-59(65-55)49-25-19-37-18-24-48-50(26-20-38-17-23-47(49)53(37)54(38)48)60-66-56(44-16-14-36-8-2-4-10-40(36)32-44)64-58(68-60)46-22-28-52-42(34-46)12-6-30-62-52;1-3-7-37-29-39(11-9-33(37)5-1)53-63-55(41-17-23-47-49(31-41)61-27-25-59-47)67-57(65-53)45-21-15-35-14-20-44-46(22-16-36-13-19-43(45)51(35)52(36)44)58-66-54(40-12-10-34-6-2-4-8-38(34)30-40)64-56(68-58)42-18-24-48-50(32-42)62-28-26-60-48;1-3-33-27-35(9-17-43(33)57-21-1)51-63-53(37-11-19-45-47(29-37)61-25-23-59-45)67-55(65-51)41-15-7-31-6-14-40-42(16-8-32-5-13-39(41)49(31)50(32)40)56-66-52(36-10-18-44-34(28-36)4-2-22-58-44)64-54(68-56)38-12-20-46-48(30-38)62-26-24-60-46/h1-34H;1-32H;1-30H
InChIKeyVJURFQRXDAGPGJ-UHFFFAOYSA-N
MW2606.89 g/mol
LogP39.45
Rot. Bonds18

About 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline

6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline (PubChem CID 161318448) has the molecular formula C174H96N30 and a molecular weight of 2606.89 g/mol. Its IUPAC name is 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline.

Molecular Properties

Compound Name6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline
PubChem CID161318448
Molecular FormulaC174H96N30
Molecular Weight2606.89 g/mol
Exact Mass2604.84
IUPAC Name6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline
SMILESc1ccc2cc(-c3nc(-c4ccc5ncccc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9ncccc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1ccc2cc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1cnc2ccc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ncccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)cc2c1
InChIInChI=1S/C60H34N8.C58H32N10.C56H30N12/c1-3-9-39-31-43(15-13-35(39)7-1)55-63-57(45-21-27-51-41(33-45)11-5-29-61-51)67-59(65-55)49-25-19-37-18-24-48-50(26-20-38-17-23-47(49)53(37)54(38)48)60-66-56(44-16-14-36-8-2-4-10-40(36)32-44)64-58(68-60)46-22-28-52-42(34-46)12-6-30-62-52;1-3-7-37-29-39(11-9-33(37)5-1)53-63-55(41-17-23-47-49(31-41)61-27-25-59-47)67-57(65-53)45-21-15-35-14-20-44-46(22-16-36-13-19-43(45)51(35)52(36)44)58-66-54(40-12-10-34-6-2-4-8-38(34)30-40)64-56(68-58)42-18-24-48-50(32-42)62-28-26-60-48;1-3-33-27-35(9-17-43(33)57-21-1)51-63-53(37-11-19-45-47(29-37)61-25-23-59-45)67-55(65-51)41-15-7-31-6-14-40-42(16-8-32-5-13-39(41)49(31)50(32)40)56-66-52(36-10-18-44-34(28-36)4-2-22-58-44)64-54(68-56)38-12-20-46-48(30-38)62-26-24-60-46/h1-34H;1-32H;1-30H
InChIKeyVJURFQRXDAGPGJ-UHFFFAOYSA-N
XLogP39.45
TPSA386.70 Ų
H-Bond Donors
H-Bond Acceptors30
Rotatable Bonds18
Heavy Atoms204
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002606.89
LogP ≤ 539.45
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline?
The IUPAC name of 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline (CID 161318448) is 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline.
What is the SMILES notation for 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline?
The canonical SMILES for 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline is c1ccc2cc(-c3nc(-c4ccc5ncccc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9ncccc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1ccc2cc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ccccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)ccc2c1.c1cnc2ccc(-c3nc(-c4ccc5nccnc5c4)nc(-c4ccc5ccc6c(-c7nc(-c8ccc9ncccc9c8)nc(-c8ccc9nccnc9c8)n7)ccc7ccc4c5c76)n3)cc2c1.
What is the InChIKey of 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline?
The InChIKey is VJURFQRXDAGPGJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C60H34N8.C58H32N10.C56H30N12/c1-3-9-39-31-43(15-13-35(39)7-1)55-63-57(45-21-27-51-41(33-45)11-5-29-61-51)67-59(65-55)49-25-19-37-18-24-48-50(26-20-38-17-23-47(49)53(37)54(38)48)60-66-56(44-16-14-36-8-2-4-10-40(36)32-44)64-58(68-60)46-22-28-52-42(34-46)12-6-30-62-52;1-3-7-37-29-39(11-9-33(37)5-1)53-63-55(41-17-23-47-49(31-41)61-27-25-59-47)67-57(65-53)45-21-15-35-14-20-44-46(22-16-36-13-19-43(45)51(35)52(36)44)58-66-54(40-12-10-34-6-2-4-8-38(34)30-40)64-56(68-58)42-18-24-48-50(32-42)62-28-26-60-48;1-3-33-27-35(9-17-43(33)57-21-1)51-63-53(37-11-19-45-47(29-37)61-25-23-59-45)67-55(65-51)41-15-7-31-6-14-40-42(16-8-32-5-13-39(41)49(31)50(32)40)56-66-52(36-10-18-44-34(28-36)4-2-22-58-44)64-54(68-56)38-12-20-46-48(30-38)62-26-24-60-46/h1-34H;1-32H;1-30H.
What are the key properties of 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline?
6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline has a molecular weight of 2606.89 g/mol, XLogP of 39.45, 18 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinolin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoline;6-[4-naphthalen-2-yl-6-[6-(4-naphthalen-2-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline;6-[4-quinolin-6-yl-6-[6-(4-quinolin-6-yl-6-quinoxalin-6-yl-1,3,5-triazin-2-yl)pyren-1-yl]-1,3,5-triazin-2-yl]quinoxaline is sourced from PubChem (CID 161318448), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).